Nat Rev Cancer

• 

  Publication Venue For

  • Author Correction: Learning to distinguish progressive and non-progressive ductal carcinoma in situ..  23:112. 2023
  • Learning to distinguish progressive and non-progressive ductal carcinoma in situ..  22:663-678. 2022
  • Leukaemia: a model metastatic disease..  21:461-475. 2021
  • Brain immunology and immunotherapy in brain tumours..  20:12-25. 2020
  • Methionine metabolism in health and cancer: a nexus of diet and precision medicine..  19:625-637. 2019
  • Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data..  19:415. 2019
  • Going to extremes: determinants of extraordinary response and survival in patients with cancer..  19:339-348. 2019
  • Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data..  19:289-297. 2019
  • A model for RAS mutation patterns in cancers: finding the sweet spot..  18:767-777. 2018
  • Transport of drugs from blood vessels to tumour tissue..  17:738-750. 2017
  • Classifying the evolutionary and ecological features of neoplasms..  17:605-619. 2017
  • Role of ABL family kinases in cancer: from leukaemia to solid tumours..  13:559-571. 2013
  • Serine, glycine and one-carbon units: cancer metabolism in full circle..  13:572-583. 2013
  • Rethinking ovarian cancer: recommendations for improving outcomes..  11:719-725. 2011
  • PTEN loss in the continuum of common cancers, rare syndromes and mouse models..  11:289-301. 2011
  • The shunt problem: control of functional shunting in normal and tumour vasculature..  10:587-593. 2010
  • Cartilage tumours and bone development: molecular pathology and possible therapeutic targets..  10:481-488. 2010
  • Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response..  8:425-437. 2008